Anne Evans Kingston
CIK: 0002127851
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PROTHENA CORP PUBLIC LTD CO
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jul 29, 2026PRTA
PROTHENA CORP PUBLIC LTD CO
Sale(S)Direct7.7K shares at avg. $8.47$65K - Jul 28, 2026PRTA
PROTHENA CORP PUBLIC LTD CO
Tax Payment(F)Direct3.5K shares at avg. $8.56$30K - Apr 10, 2026PRTA
PROTHENA CORP PUBLIC LTD CO
Award(A)DirectStock Option (Right to Buy)
100K shares-
1-3 of 3 transactions
About Kingston Anne Evans
Kingston Anne Evans (SEC CIK 0002127851) files insider reports with the SEC as Chief Strategy Officer of PROTHENA CORP PUBLIC LTD CO (PRTA).
Signal8 holds 3 ownership filings by Kingston Anne Evans (1 Form 3, 2 Form 4), filed between Apr 10, 2026 and Jul 30, 2026. Those filings report 3 transactions, from Apr 10, 2026 to Jul 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kingston Anne Evans's filings is in BRISBANE, CA.
Recent filings by Kingston Anne Evans
Other insiders filing for PROTHENA CORP PUBLIC LTD CO (PRTA)
- SCULLY WILLIAM P, 10% Owner
- Fennell Todd W., 10% Owner
- Zago Wagner M., Chief Scientific Officer
- Walker Karin L, Chief Accounting Officer
- Swanson Chad J., Chief Development Officer
- Smith Brandon S., Chief Operating Officer